查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1587585

骨形成蛋白市场规模、份额、趋势分析报告：按类型、应用、区域、细分市场预测，2025-2030

Bone Morphogenetic Protein Market Size, Share & Trends Analysis Report By Type (rhBMP-2, rhBMP-7), By Application (Spinal Fusion, Trauma, Reconstruction, Oral Maxillofacial), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

骨形成蛋白市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计到2030年，全球骨形成蛋白市场规模将达到4.599亿美元，2025年至2030年复合年增长率为4.93%。

脊椎融合手术、创伤、听骨手术发生率的增加以及对更快骨骼恢復的需求是确保 BMP 市场成长的主要因素。

腰痛和椎间盘脱位是最常见的职业病。超过 75% 的此类疾病无法透过非侵入性治疗方法缓解，需要进行脊椎手术。微创手术、缩短住院时间、加速復原速度是患者的普遍诉求。由于上述优点，BMP近年来受到骨科医生的欢迎。

运动相关损伤、老年人口的增加以及骨诱导产品作为骨移植替代品的认识不断提高也是推动市场成长的因素。据报导，BMP 的结果优于骨移植，包括无捐赠者发病率、广泛的外科手术、恢復时间长、疼痛和麻木以及高成本。

骨形成蛋白市场报告亮点：

  • rhBMP-2和rhBMP-7是市售的重组BMP。 rhBMP-2 因其高度骨诱导特性而广为人知，可在骨融合手术中加速骨骼和软骨的形成。
  • rhBMP-2 细分市场在 2024 年占据最大市场占有率，达到 73.9%，预计 2025 年至 2030 年将以更高的复合年增长率成长。
  • rhBMP-7 细分市场预计从 2025 年到 2030 年将以适度的复合年增长率成长。随着医疗保健专业人员越来越多地寻求自体移植骨骼修復的替代品，rhBMP-7 促进癒合且没有与移植物收穫相关的併发症的能力将促进其在临床环境中的采用。
  • 脊椎融合手术领域占最大市场占有率，2024年将达50.3%。这种增长是由有效和高效的解决方案的开发、这些蛋白质相对于传统治疗方法的接受度的提高以及旨在加强其市场地位的持续研究倡议所推动的。
  • 2024年，北美在全球骨形成蛋白市场中占据最大市场占有率，达到49.6%。最大的市占率归因于整形外科手术量大和有利的报销政策。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章骨形成蛋白市场：按类型进行的业务分析

  • 类型细分仪表板
  • 全球骨形成蛋白市场类型波动分析
  • 2018-2030年全球骨形成蛋白市场规模及趋势分析（依类型）
  • 重组HBMP-2基因
  • 重组HBMP-7基因

第五章骨形成蛋白市场：应用业务分析

  • 使用细分仪表板
  • 全球骨形成蛋白市场应用变化分析
  • 2018-2030年全球骨形成蛋白市场规模及趋势分析（依应用）
  • 脊椎融合手术
  • 创伤
  • 重组
  • 口腔颚颜面

第六章骨形成蛋白市场：按类型和应用分類的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模及预测及趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 参与企业
  • 策略规划
  • 2024 年企业市场分析
  • 参与企业概况
    • Medtronic plc
    • Cellumed Co., Ltd.
    • Cell Guidance Systems LLC
    • Merck KGaA
    • Prospec-Tany Technogene Ltd.
    • Qkine Ltd.
    • Bio-Techne.
    • Thermo Fisher Scientific Inc.
    • Proteintech Group, Inc.
    • STEMCELL Technologies
    • Sartorius Stedim Biotech
Product Code: GVR-1-68038-226-6

Bone Morphogenetic Protein Market Growth & Trends:

The global bone morphogenetic protein market size is expected to reach USD 459.9 million by 2030, registering a CAGR of 4.93% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of spinal fusion, trauma, and small bone surgeries coupled with demand for faster bone recovery are the key drivers affirming growth of BMP market.

Low back pain and spinal disc dislocation are some of the most common occupational hazards. Over 75% of such disorders require spinal surgery after noninvasive treatment options are unable to provide any relief. Minimally invasive surgery, shorter hospital stays, and fast recovery are common demands observed among patients. BMP has gained high acceptance among orthopedic surgeons in recent years owing to its ability to cater above mentioned benefits

Sport-related injuries, growing geriatric population, and increasing awareness about osteoinduction products as an alternative to bone grafting are other drivers accentuating market growth. BMP has reported outstanding results over bone graft, such as lack of donor morbidity, extensive surgical procedure, higher recovery time, pain & numbness, and high cost.

Bone Morphogenetic Protein Market Report Highlights:

  • rhBMP-2 and rhBMP-7 are the commercially available recombinant BMPs. rhBMP-2 is widely known for its high osteoinductive property for faster formation of bone and cartilage in bone fusion procedures.
  • The rhBMP-2 segment held the largest market share of 73.9% in 2024 and is anticipated to grow at the higher CAGR from 2025 to 2030.
  • rhBMP-7 segment is expected to grow at a moderate CAGR from 2025 to 2030. As healthcare professionals increasingly look for alternatives to autografts for bone repair, rhBMP-7's ability to promote healing without the complications associated with harvesting grafts could drive its adoption in clinical practice.
  • The spinal fusion segment held the largest market share of 50.3% in 2024. The growth is attributed to the development of effective and efficient solutions, the increasing acceptance of these proteins over conventional treatments, and the ongoing research initiatives that strengthen their position in the market.
  • North America held the largest market share of 49.6% in the global bone morphogenetic protein market in 2024. High number of orthopedic surgical procedures, and availability of favorable reimbursement policies are drivers that can be attributed to for largest share.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Application Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing demand for minimally invasive medical procedures
      • 3.2.1.2. Increasing incidence of sports-related injuries
      • 3.2.1.3. Increasing target population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Complications associated with the use of Bone Morphogenic Proteins
      • 3.2.2.2. Availability of alternative treatments
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Bone Morphogenetic Protein Market: Type Business Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Global Bone Morphogenetic Protein Market Type Movement Analysis
  • 4.3. Global Bone Morphogenetic Protein Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. rhBMP-2
    • 4.4.1. Global rhBMP-2 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. rhBMP-7
    • 4.5.1. Global rhBMP-7 Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Bone Morphogenetic Protein Market: Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Bone Morphogenetic Protein Market Application Movement Analysis
  • 5.3. Global Bone Morphogenetic Protein Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Spinal Fusion
    • 5.4.1. Global Spinal Fusion Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Trauma
    • 5.5.1. Global TraumaMarket Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Reconstruction
    • 5.6.1. Global Reconstruction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Oral Maxillofacial
    • 5.7.1. Global Oral Maxillofacial Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Bone Morphogenetic Protein Market: Regional Estimates & Trend Analysis by Type and Application

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. North America Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Market and Competitive Scenario
      • 6.3.2.3. U.S. Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Market and Competitive Scenario
      • 6.3.3.3. Canada Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Market and Competitive Scenario
      • 6.3.4.3. Mexico Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Market and Competitive Scenario
      • 6.4.2.3. UK Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Market and Competitive Scenario
      • 6.4.3.3. Germany Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Market and Competitive Scenario
      • 6.4.4.3. France Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Market and Competitive Scenario
      • 6.4.5.3. Italy Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Market and Competitive Scenario
      • 6.4.6.3. Spain Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Market and Competitive Scenario
      • 6.4.7.3. Denmark Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.8. Sweden
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Market and Competitive Scenario
      • 6.4.8.3. Sweden Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Market and Competitive Scenario
      • 6.4.9.3. Norway Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Market and Competitive Scenario
      • 6.5.2.3. Japan Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Market and Competitive Scenario
      • 6.5.3.3. China Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Market and Competitive Scenario
      • 6.5.4.3. India Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Market and Competitive Scenario
      • 6.5.5.3. Australia Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Market and Competitive Scenario
      • 6.5.6.3. Thailand Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Market and Competitive Scenario
      • 6.5.7.3. South Korea Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Market and Competitive Scenario
      • 6.6.2.3. Brazil Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Market and Competitive Scenario
      • 6.6.3.3. Argentina Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Market and Competitive Scenario
      • 6.7.2.3. South Africa Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Market and Competitive Scenario
      • 6.7.3.3. Saudi Arabia Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Market and Competitive Scenario
      • 6.7.4.3. UAE Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Market and Competitive Scenario
      • 6.7.5.3. Kuwait Bone Morphogenetic Protein Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Participant's Overview
    • 7.4.1. Medtronic plc
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Cellumed Co., Ltd.
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Cell Guidance Systems LLC
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Merck KGaA
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Prospec-Tany Technogene Ltd.
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Qkine Ltd.
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Bio-Techne.
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Thermo Fisher Scientific Inc.
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Proteintech Group, Inc.
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. STEMCELL Technologies
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Sartorius Stedim Biotech
      • 7.4.11.1. Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global Bone Morphogenetic Protein market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global Bone Morphogenetic Protein market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America Bone Morphogenetic Protein market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America Bone Morphogenetic Protein market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Bone Morphogenetic Protein market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 13 Mexico Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 14 Mexico Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 15 Europe Bone Morphogenetic Protein market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 17 Europe Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 18 UK Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 19 UK Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 20 Germany Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 21 Germany Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 22 France Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 23 France Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 24 Italy Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 25 Italy Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 26 Spain Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 27 Spain Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 28 Denmark Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 29 Denmark Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 30 Sweden Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 31 Sweden Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 32 Norway Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 33 Norway Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Bone Morphogenetic Protein market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 37 Japan Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 38 Japan Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 39 China Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 40 China Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 41 India Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 42 India Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 43 Australia Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 44 Australia Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 45 Thailand Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 46 Thailand Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 47 South Korea Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 48 South Korea Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 49 Latin America Bone Morphogenetic Protein market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 51 Latin America Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 52 Brazil Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 53 Brazil Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 54 Argentina Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 55 Argentina Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Bone Morphogenetic Protein market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 59 South Africa Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 60 South Africa Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 63 UAE Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 64 UAE Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 65 Kuwait Bone Morphogenetic Protein market, by type, 2018 - 2030 (USD Million)
  • Table 66 Kuwait Bone Morphogenetic Protein market, by application , 2018 - 2030 (USD Million)
  • Table 67 Participant's overview
  • Table 68 Financial performance

List of Figures

  • Fig. 1 Bone Morphogenetic Protein market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Bone Morphogenetic Protein market driver analysis
  • Fig. 12 Bone Morphogenetic Protein market restraint analysis
  • Fig. 13 Bone Morphogenetic Protein market: Porter's analysis
  • Fig. 14 Bone Morphogenetic Protein market: PESTEL analysis
  • Fig. 15 Bone Morphogenetic Protein market: Type outlook and key takeaways
  • Fig. 16 Bone Morphogenetic Protein market: Type market share analysis, 2023 - 2030
  • Fig. 17 rhBMP-2 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 rhBMP-7 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Bone Morphogenetic Protein market: Application outlook and key takeaways
  • Fig. 20 Bone Morphogenetic Protein market: Application market share analysis, 2023 - 2030
  • Fig. 21 Spinal Fusion market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Trauma market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Recontructive market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Oral Maxillofacial market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Regional marketplace: Key takeaways
  • Fig. 26 North America Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Canada Bone Morphogenetic Protein market, 2018 - 2030 (USD Million)
  • Fig. 29 Mexico Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Europe Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 UK Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Germany Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 France Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Italy Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Spain Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Denmark Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Sweden Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Norway Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Asia-Pacific Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Japan Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 China Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 India Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Australia Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 South Korea Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Latin America Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Brazil Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 MEA Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 UAE Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait Bone Morphogenetic Protein market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Key company categorization
  • Fig. 55 Company market positioning
  • Fig. 56 Market participant categorization
  • Fig. 57 Strategy framework